BHC | tickerfilter.com

Fundamental analysis

56%

Profitability 55%

Dept financing 43%

Liquidity 63%

Performance 59%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

-2.88%

1 Month

12.35%

3 Months

-12.79%

6 Months

-8.17%

1 Year

10.40%

2 Year

-25.58%

Key data

Stock price

$5.73

P/E Ratio

16.40

DAY RANGE

$5.71 - $5.92

EPS

$0.42

52 WEEK RANGE

$4.41 - $8.68

52 WEEK CHANGE

$10.83

MARKET CAP

2.575 B

YIELD

N/A

SHARES OUTSTANDING

370.562 M

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

07-30-2025

BETA

0.00

PUBLIC FLOAT

N/A

AVERAGE 10 VOLUME

$1,087,498

AVERAGE 30 VOLUME

$1,269,369

Company detail

CEO: Thomas J. Appio
Region: US
Website: bauschhealth.com
Employees: 19,900
IPO year: 2006

Issue type:
Market: NYSE
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

Bausch Health Companies Inc. develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products. The Salix segment provides gastroenterology products in the United States. The Ortho Dermatologics segment provides dermatological products in United States; and Solta medical aesthetic devices internationally.

BHC - Bausch Health Companies Inc.